Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 09-2018 | 09-2017 | |
| Sales | 23,167 | 22,752 | 16,459 | 1,316 | 129 |
| Cost of Goods | 2,248 | 1,094 | 993 | 827 | 54 |
| Gross Profit | 20,919 | 21,658 | 15,466 | 488 | 75 |
| Operating Expenses | 21,199 | 26,264 | 24,913 | 11,560 | 7,232 |
| Operating Income | -32 | -4,512 | -8,454 | -10,245 | -7,104 |
| Interest Expense | 5,989 | 27,625 | 22,796 | 86 | 7 |
| Other Income | 6,994 | -22,541 | -41,298 | 0 | 0 |
| Pre-tax Income | 973 | -54,678 | -72,548 | -10,331 | -7,110 |
| Income Tax | -381 | 164 | 39 | 2 | 3 |
| Net Income Continuous | 1,354 | -54,842 | -72,587 | -10,333 | -7,113 |
| Minority Interests | N/A | N/A | N/A | -734 | N/A |
| Net Income | $1,354 | $-54,842 | $-72,587 | $-9,599 | $-7,113 |
| EPS Basic Total Ops | 0.03 | -1.30 | -1.97 | -11.16 | -15.12 |
| EPS Basic Continuous Ops | 0.03 | -1.30 | -1.97 | -11.92 | -15.15 |
| EPS Diluted Total Ops | 0.03 | -1.30 | -1.97 | -11.16 | -15.12 |
| EPS Diluted Continuous Ops | 0.03 | -1.30 | -1.97 | -11.92 | -15.15 |
| EPS Diluted Before Non-Recurring Items | 0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $4,055 | $19,342 | $9,841 | $-10,045 | $-7,055 |